Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

HCATHCAT
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in HEALTH CATALYST INC

GOLDMAN SACHS GROUP INC holds 480,970 shares of HCAT (HEALTH CATALYST INC), worth $957,130 as of 2026-Q2. The position was increased (+24.2% shares). HCAT represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$957,130

Current Shares

480,970

Total Value Change

-$5.3M

Total Shares Change

-405,697

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
480,970
+24.2%
$957,1300.0%$1.99
30
2026-Q1
Increased
387,172
+22.2%
$491,7080.0%$1.72
29
2025-Q4
Decreased
316,802
-43.4%
$757,1560.0%$2.38
0
2025-Q3
Increased
559,652
+35.2%
$1.6M0.0%$2.92
33
2025-Q2
Decreased
413,912
-25.6%
$1.6M0.0%$3.81
0
2025-Q1
Decreased
555,925
-37.3%
$2.5M0.0%$4.55
0
2024-Q4
New
886,667
-
$6.3M0.0%$7.01
38

Other major holders of HCAT: SC US (TTGP), LTD., Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used